News

PacBio’s first quarter of 2025 was shaped by ongoing funding constraints in the academic and research sector, as well as ...
Pacific Biosciences of California (NASDAQ:PACB) ranks among the best CRISPR stocks to buy. Speaking on its strategic ...
Pacific Biosciences of California (PACB) closed the most recent trading day at $1.24, moving -3.88% from the previous trading ...
The NSC, led by Professor Kjetill S. Jakobsen and supported by Lab Manager Dr. Ave Tooming-Klunderud , is a leading center of ...
Ratings for Pacific Biosciences PACB +0.01% Get Free Report were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
Paraphase – a computational tool that accurately resolves and analyzes paralogous genes – unlocks the difficult-to-analyze ...
Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.